NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
0.8800
+0.0300 (3.53%)
At close: Feb 6, 2026, 4:00 PM EST
0.9587
+0.0787 (8.94%)
Pre-market: Feb 9, 2026, 8:00 AM EST

NanoViricides Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Selling, General & Admin
3.614.043.082.552.332.63
Research & Development
4.615.555.446.395.786.11
Operating Expenses
8.229.598.528.948.118.74
Operating Income
-8.22-9.59-8.52-8.94-8.11-8.74
Interest Expense
-0-0-0.05-0-0.01-0.09
Interest & Investment Income
0.10.120.270.360.010.01
EBT Excluding Unusual Items
-8.13-9.47-8.29-8.59-8.11-8.82
Gain (Loss) on Sale of Assets
------0
Pretax Income
-8.13-9.47-8.29-8.59-8.11-8.82
Net Income
-8.13-9.47-8.29-8.59-8.11-8.82
Net Income to Common
-8.13-9.47-8.29-8.59-8.11-8.82
Shares Outstanding (Basic)
161512121211
Shares Outstanding (Diluted)
161512121211
Shares Change (YoY)
29.00%27.34%2.11%0.79%5.81%94.08%
EPS (Basic)
-0.51-0.63-0.70-0.74-0.70-0.81
EPS (Diluted)
-0.51-0.63-0.70-0.74-0.70-0.81
Free Cash Flow
-7.57-8.54-6.47-5.82-6.22-8.45
Free Cash Flow Per Share
-0.47-0.56-0.55-0.50-0.54-0.78
EBITDA
-7.54-8.85-7.76-8.2-7.39-8.04
D&A For EBITDA
0.680.740.760.750.720.7
EBIT
-8.22-9.59-8.52-8.94-8.11-8.74
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q